Navigation Links
US Representative Mike Fitzpatrick Tours US BioDesign Manufacturing Facility
Date:9/6/2013

QUAKERTOWN, Pa., Sept. 6, 2013 /PRNewswire-iReach/ -- On August 28, Tom Molz, Founder and President of US BioDesign LLC, a premier supplier of implantable biomedical textile components to the global medical device industry, led civic and business leaders including US Representative Mike Fitzpatrick on a tour of the company's newly relocated offices and manufacturing facility in Quakertown, Pennsylvania. Congressman Fitzpatrick congratulated US BioDesign's commitment to expanding local manufacturing job opportunities. Pennsylvania Senator Bob Mensch also cited the company's commitment to manufacturing excellence and fostering regional economic growth.

(Photo: http://photos.prnewswire.com/prnh/20130906/MN75226)

The tour spotlighted US BioDesign's highly specialized capabilities, clean room technology and state-of-the-art manufacturing equipment, which includes the world's largest medical braider and custom-designed processes for non-woven medical felts. According to Mr. Molz, the facility expansion supports the company's business strategy for remaining competitive, despite the Affordable Care Act's economic impact on the global medical device industry.

"The Affordable Care Act mandates a 2.3% tax on the sale of medical devices which means our customers have to do more with less," said Keith Smith, Director of Business Development.  "Our streamlined approach to new product development enables the most cost effective use of resources, helping medical device companies address this challenge," he continued.

According to Mr. Molz, unlike some long established suppliers to the medical device industry, US BioDesign is a new company with an agile and flexible operating structure designed to support its singular founding mission: To serve the medical device industry as a highly capable, yet cost efficient supplier of engineered medical textiles, biomedical structures and implantable fabrics.  "Our business strategy," he said, "advances that mission and positions US BioDesign as the foremost industry resource for expert, highly reliable, highly capable, high quality yet cost efficient medical fabric development and manufacturing solutions."

"What you see is what you get - a smart, competitive company with an operating structure that's only as big as it needs to be, and agile and flexible enough to respond to changing industry dynamics without compromising quality or cost efficiency," commented Mr. Smith.

US BioDesign employees combine some 100 years of expertise in biomaterials and medical fabric design, development and manufacturing.  "The extensive medical device industry knowledge and expertise of our leadership and engineering teams can help medical device companies control R&D costs despite current and emerging economic challenges," said Mr. Molz.

US BioDesign Founder Tom Molz has driven discovery and innovation within the medical/biomedical textiles and implantable fabrics for medical devices industry for more than 20 years, and has been involved with biomedical textile developments in virtually all areas of the medical device industry. US BioDesign is the second biomedical manufacturing company founded by Mr. Molz.  Keith Smith brings extensive experience in bio-materials and textile structures used for implantable medical device components, in addition to leading business development and managing strategic client relationships for US BioDesign.

About US BioDesign

US BioDesign is a global leader in the development and manufacture of biomedical textile structures for medical devices across the cardiovascular, neurological and general surgery segments of the health care industry.   The company draws upon deep biomedical engineering expertise and an unparalleled understanding of medical device construct development involving polymeric and/or metallic raw materials to deliver elegant and efficient engineering solutions and commercial development support.  Founded in 2011, US BioDesign serves the global medical device industry, specializing in braided and non-woven components. 

Contact

US BioDesign LLC
Keith Smith, Director of Business Development
P: 267- 450-8860, x210
E: ksmith@usbiodesign.com

www.usbiodesign.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE US BioDesign LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HemoShear Co-Founder Presents Recommendations for Funding of Breakthrough Technologies to U.S. House of Representatives Committee on Science, Engineering and Technology
2. PCMA: 88 U.S. Representatives Urge USPS to Preserve Six Day Delivery of Mail-Service Pharmacy
3. Doug Zitnak of Upsher-Smith Laboratories Named Small Brand Manufacturer Representative of the Year By Cardinal Health
4. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
5. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
6. US BioDesign Relocation Expands Manufacturing Capabilities
7. Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023
8. Injectable Dose Formulations Highly Impact Global Pharmaceutical Contract Manufacturing Vendor Revenues
9. InspireMD Completes First Phase of Manufacturing Upgrade and Partners with HealthLink for Global Logistics and Distribution Services
10. China Orthopedic Devices Market, Contract Manufacturing in Orthopedic Industry Reports
11. European Union Grants a Good Manufacturing Practice Certificate to Nelson Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
(Date:4/19/2017)... -- Cardiology devices segment is anticipated to reach the highest ... Devices segment is likely to create absolute $ opportunity of ... 2017. By the end of 2027, Cardiology Devices segment is ... Mn, expanding at a CAGR of 18.4% over the forecast ... Pacific reprocessed medical devices market in terms of ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
Breaking Medicine Technology:
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... 2017 , ... The National Business Research Institute (NBRI) is ... Emergency Medical Technicians and welcomes this organization to the NBRI Circle of ... Ph.D. , CEO & Organizational Psychologist at NBRI. “This award is a result ...
(Date:4/26/2017)... ST. LOUIS (PRWEB) , ... April 26, 2017 ... ... is designed specifically to improve the profitability of ready-to-drink, high-protein beverages by helping ... an economic alternative to dairy proteins, providing direct cost savings as well as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical Therapy ... the preferred physical therapy provider for Derby City CrossFit, effective immediately. , In ... as quickly and effectively as possible, ProRehab’s sports physical therapists will work with ...
(Date:4/25/2017)... ... , ... The doctors at Wall Centre Dental are now expanding their practice ... sedation to receive dental care. The doctors offer three treatment options to put victims ... oral surgery, at their dental office in Vancouver. Wall Centre Dental is currently welcoming ...
Breaking Medicine News(10 mins):